vs
Side-by-side financial comparison of AMN HEALTHCARE SERVICES INC (AMN) and Dexcom (DXCM). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $748.2M, roughly 1.7× AMN HEALTHCARE SERVICES INC). Dexcom runs the higher net margin — 21.2% vs -1.0%, a 22.2% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 1.8%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -4.5%).
AMN Healthcare Services Inc. is a leading US healthcare sector workforce solutions and staffing provider. It offers temporary and permanent placement for nurses, physicians, allied health and other clinical/non-clinical staff, plus workforce management tools and consulting for hospitals, clinics and other medical facilities.
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
AMN vs DXCM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $748.2M | $1.3B |
| Net Profit | $-7.7M | $267.3M |
| Gross Margin | 26.1% | 62.9% |
| Operating Margin | 1.1% | 25.6% |
| Net Margin | -1.0% | 21.2% |
| Revenue YoY | 1.8% | 21.6% |
| Net Profit YoY | 95.9% | 153.6% |
| EPS (diluted) | $-0.19 | $0.67 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | $748.2M | $1.3B | ||
| Q3 25 | $634.5M | $1.2B | ||
| Q2 25 | $658.2M | $1.2B | ||
| Q1 25 | $689.5M | $1.0B | ||
| Q4 24 | $734.7M | $1.1B | ||
| Q3 24 | $687.5M | $994.2M | ||
| Q2 24 | $740.7M | $1.0B |
| Q1 26 | — | $267.3M | ||
| Q4 25 | $-7.7M | $267.3M | ||
| Q3 25 | $29.3M | $283.8M | ||
| Q2 25 | $-116.2M | $179.8M | ||
| Q1 25 | $-1.1M | $105.4M | ||
| Q4 24 | $-187.5M | $151.7M | ||
| Q3 24 | $7.0M | $134.6M | ||
| Q2 24 | $16.2M | $143.5M |
| Q1 26 | — | 62.9% | ||
| Q4 25 | 26.1% | 62.9% | ||
| Q3 25 | 29.1% | 60.5% | ||
| Q2 25 | 29.8% | 59.5% | ||
| Q1 25 | 28.7% | 56.9% | ||
| Q4 24 | 29.8% | 58.9% | ||
| Q3 24 | 31.0% | 59.7% | ||
| Q2 24 | 31.0% | 62.4% |
| Q1 26 | — | 25.6% | ||
| Q4 25 | 1.1% | 25.6% | ||
| Q3 25 | 7.5% | 20.1% | ||
| Q2 25 | -18.8% | 18.4% | ||
| Q1 25 | 1.8% | 12.9% | ||
| Q4 24 | -27.6% | 17.0% | ||
| Q3 24 | 3.2% | 15.3% | ||
| Q2 24 | 5.1% | 15.7% |
| Q1 26 | — | 21.2% | ||
| Q4 25 | -1.0% | 21.2% | ||
| Q3 25 | 4.6% | 23.5% | ||
| Q2 25 | -17.7% | 15.5% | ||
| Q1 25 | -0.2% | 10.2% | ||
| Q4 24 | -25.5% | 13.6% | ||
| Q3 24 | 1.0% | 13.5% | ||
| Q2 24 | 2.2% | 14.3% |
| Q1 26 | — | $0.67 | ||
| Q4 25 | $-0.19 | $0.67 | ||
| Q3 25 | $0.76 | $0.70 | ||
| Q2 25 | $-3.02 | $0.45 | ||
| Q1 25 | $-0.03 | $0.27 | ||
| Q4 24 | $-4.90 | $0.37 | ||
| Q3 24 | $0.18 | $0.34 | ||
| Q2 24 | $0.42 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.0M | $917.7M |
| Total DebtLower is stronger | $767.1M | — |
| Stockholders' EquityBook value | $642.1M | $2.7B |
| Total Assets | $2.1B | $6.3B |
| Debt / EquityLower = less leverage | 1.19× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $917.7M | ||
| Q4 25 | $34.0M | $917.7M | ||
| Q3 25 | $52.6M | $1.8B | ||
| Q2 25 | $41.5M | $1.2B | ||
| Q1 25 | $55.8M | $904.9M | ||
| Q4 24 | $10.6M | $606.1M | ||
| Q3 24 | $30.6M | $621.2M | ||
| Q2 24 | $48.0M | $939.2M |
| Q1 26 | — | — | ||
| Q4 25 | $767.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $2.7B | ||
| Q4 25 | $642.1M | $2.7B | ||
| Q3 25 | $644.4M | $2.7B | ||
| Q2 25 | $607.6M | $2.6B | ||
| Q1 25 | $715.1M | $2.3B | ||
| Q4 24 | $706.6M | $2.1B | ||
| Q3 24 | $890.7M | $2.0B | ||
| Q2 24 | $876.9M | $2.4B |
| Q1 26 | — | $6.3B | ||
| Q4 25 | $2.1B | $6.3B | ||
| Q3 25 | $2.1B | $7.5B | ||
| Q2 25 | $2.2B | $7.3B | ||
| Q1 25 | $2.4B | $6.8B | ||
| Q4 24 | $2.4B | $6.5B | ||
| Q3 24 | $2.7B | $6.4B | ||
| Q2 24 | $2.8B | $6.8B |
| Q1 26 | — | — | ||
| Q4 25 | 1.19× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.6M | — |
| Free Cash FlowOCF − Capex | $67.6M | — |
| FCF MarginFCF / Revenue | 9.0% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $233.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $75.6M | $294.0M | ||
| Q3 25 | $22.7M | $659.9M | ||
| Q2 25 | $78.5M | $303.0M | ||
| Q1 25 | $92.7M | $183.8M | ||
| Q4 24 | $72.8M | $301.4M | ||
| Q3 24 | $66.7M | $199.5M | ||
| Q2 24 | $99.5M | $279.4M |
| Q1 26 | — | — | ||
| Q4 25 | $67.6M | $192.1M | ||
| Q3 25 | $14.8M | $579.4M | ||
| Q2 25 | $68.7M | $208.9M | ||
| Q1 25 | $82.7M | $96.8M | ||
| Q4 24 | $56.6M | $176.8M | ||
| Q3 24 | $47.4M | $88.3M | ||
| Q2 24 | $72.2M | $213.3M |
| Q1 26 | — | — | ||
| Q4 25 | 9.0% | 15.3% | ||
| Q3 25 | 2.3% | 47.9% | ||
| Q2 25 | 10.4% | 18.1% | ||
| Q1 25 | 12.0% | 9.3% | ||
| Q4 24 | 7.7% | 15.9% | ||
| Q3 24 | 6.9% | 8.9% | ||
| Q2 24 | 9.8% | 21.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | 8.1% | ||
| Q3 25 | 1.2% | 6.7% | ||
| Q2 25 | 1.5% | 8.1% | ||
| Q1 25 | 1.4% | 8.4% | ||
| Q4 24 | 2.2% | 11.2% | ||
| Q3 24 | 2.8% | 11.2% | ||
| Q2 24 | 3.7% | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.10× | ||
| Q3 25 | 0.77× | 2.33× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | 1.74× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | 9.54× | 1.48× | ||
| Q2 24 | 6.13× | 1.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMN
| Travel Nurse Staffing | $208.3M | 28% |
| Allied Staffing | $146.9M | 20% |
| Labor Disruption Services | $124.3M | 17% |
| Technology And Workforce Solutions | $88.0M | 12% |
| Language Services | $69.9M | 9% |
| Other | $29.6M | 4% |
| International Nurse Staffing | $29.6M | 4% |
| Interim Leadership Staffing | $24.1M | 3% |
| Vendor Management Systems | $16.3M | 2% |
| Local Staffing | $8.6M | 1% |
| International Nurse Permanent Placement | $2.6M | 0% |
DXCM
Segment breakdown not available.
